Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer
for
Ovarian Cancer, Stage III Ovarian Cancer,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: Female
Age: 18+
Code: NCT05961124
Phase 2, Recruiting
Evaluation of Food Additive Contributions to Obesity: Pilot Study 1
for
Obesity (Disorder)
Location: Hamilton
Sponsor: McMaster University
Sex: All
Age: 20 - 70+
Code: NCT07437430
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: Toronto, Scarborough Village, Oakville, St. Catharines,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT04774159
Phase 3, Recruiting
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
for
Thalassemia in Children
Location: Toronto
Sponsor: The Hospital for Sick Children
Sex: All
Age: 1 - 18
Code: NCT05426252
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)
for
Atrial Fibrillation (AF), Atrial Flutter
Location: Toronto, Ottawa, Hershey PA
Sponsor: Ottawa Heart Institute Research Corporation
Sex: All
Age: 18+
Code: NCT07002450
Recruiting
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
for
Renal Cell Carcinoma
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT05023265
Recruiting
A Phase II Trial Evaluating Radiation Boost to Painful Spinal Metastases
for
Spine Metastasis
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT07478289
Phase 2, Recruiting
A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Toronto, Montreal, Fredericton
Sponsor: Nura Bio
Sex: All
Age: 18 - 70+
Code: NCT07369076
Phase 1, Phase 2, Recruiting
Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma
for
Glioblastoma
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 65+
Code: NCT07476794
Phase 2, Recruiting
Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study
for
Solid Tumor Malignancies, Brain Metastasases,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT07476781
Recruiting
Evaluation of Intercostal Neuralgia in Patients With Chest Tube Insertion After Traumatic Rib Fracture
for
Intercostal Nerve Injury
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT07308587
Recruiting
Assessment of Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Disorders of Consciousness
for
Disorders of Consciousness Due to Severe Brain Injury,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 0+
Code: NCT07694258
Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Toronto, Knoxville TN, Nashville TN, St Louis MO,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07544654
Phase 3, Recruiting
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
for
Prostate Cancer Screening
Location: Toronto, Vancouver, Los Angeles CA
Sponsor: University of Alberta
Sex: Male
Age: 50 - 70
Code: NCT06626022
Phase 3, Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Hamilton, Pittsburgh PA, Montreal, New York NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
Comparing Virtual Reality Simulation to High Fidelity Simulation as an Educational Modality for Electroconvulsive Therapy Training: A Non-Inferiority Study